Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dahler

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
European Urology|October 1, 2016
Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical TrialDonald Newgreen, Brigitte Bosman, Adriana Hollestein-Havelaar, et al.
Forschende Komplementarmedizin (2006)|May 18, 2011
[Legal status and organization of homeopathic drug testing in Germany]Michael Teut, Ute Hirschberg, Michael K Elies, et al.
Research and Practice in Thrombosis and Haemostasis|May 1, 2026
Analytical validity of the INNOVANCE Antithrombin assay for the measurement of antithrombin activity at fitusiran clinical decision pointsChristoph Freidel, Martina Boehm-Weigert, Christine Dahler, et al.
The Journal of Urology|May 17, 2017
Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive BladderDonald Newgreen, Brigitte Bosman, Adriana Hollestein-Havelaar, et al.
The Journal of Investigative Dermatology|January 21, 2011
Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1Mehlika Hazar-Rethinam, Sarina R Cameron, Alison L Dahler, et al.
The Journal of Investigative Dermatology|May 2, 2002
Isolation (from a basal cell carcinoma) of a functionally distinct fibroblast-like cell type that overexpresses PtchAnthony J Dicker, Magdalena M Serewko, Terry Russell, et al.
Oncogene|March 1, 2005
E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell lineChung Fai Wong, Liam M Barnes, Alison L Dahler, et al.
Oncogene|June 29, 2000
E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytesA J Dicker, C Popa, A L Dahler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
ICOS controls the pool size of effector-memory and regulatory T cellsYvonne Burmeister, Timo Lischke, Anja C Dahler, et al.
Cancer Research|July 5, 2002
Alterations in gene expression and activity during squamous cell carcinoma developmentMagdalena M Serewko, Claudia Popa, Alison L Dahler, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
European Urology|October 1, 2016
Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical TrialDonald Newgreen, Brigitte Bosman, Adriana Hollestein-Havelaar, et al.
Forschende Komplementarmedizin (2006)|May 18, 2011
[Legal status and organization of homeopathic drug testing in Germany]Michael Teut, Ute Hirschberg, Michael K Elies, et al.
Research and Practice in Thrombosis and Haemostasis|May 1, 2026
Analytical validity of the INNOVANCE Antithrombin assay for the measurement of antithrombin activity at fitusiran clinical decision pointsChristoph Freidel, Martina Boehm-Weigert, Christine Dahler, et al.
The Journal of Urology|May 17, 2017
Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive BladderDonald Newgreen, Brigitte Bosman, Adriana Hollestein-Havelaar, et al.
The Journal of Investigative Dermatology|January 21, 2011
Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1Mehlika Hazar-Rethinam, Sarina R Cameron, Alison L Dahler, et al.
The Journal of Investigative Dermatology|May 2, 2002
Isolation (from a basal cell carcinoma) of a functionally distinct fibroblast-like cell type that overexpresses PtchAnthony J Dicker, Magdalena M Serewko, Terry Russell, et al.
Oncogene|March 1, 2005
E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell lineChung Fai Wong, Liam M Barnes, Alison L Dahler, et al.
Oncogene|June 29, 2000
E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytesA J Dicker, C Popa, A L Dahler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
ICOS controls the pool size of effector-memory and regulatory T cellsYvonne Burmeister, Timo Lischke, Anja C Dahler, et al.
Cancer Research|July 5, 2002
Alterations in gene expression and activity during squamous cell carcinoma developmentMagdalena M Serewko, Claudia Popa, Alison L Dahler, et al.
Pageof 9